These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3038273)

  • 1. Effects of low calcium and inhibition of calcium-activated neutral protease (CANP) on mature nerve terminal structure in the rat sternocostalis muscle.
    Swanson GJ; Vrbová G
    Brain Res; 1987 Jun; 430(2):199-203. PubMed ID: 3038273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low calcium and protease inhibitors on synapse elimination during postnatal development in the rat soleus muscle.
    Connold AL; Evers JV; Vrbová G
    Brain Res; 1986 Jul; 393(1):99-107. PubMed ID: 3015360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilisation of neuromuscular junctions by leupeptin increases motor unit size in partially denervated rat muscles.
    Tyc F; Vrbová G
    Brain Res Dev Brain Res; 1995 Sep; 88(2):186-93. PubMed ID: 8665665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition.
    Atsma DE; Bastiaanse EM; Jerzewski A; Van der Valk LJ; Van der Laarse A
    Circ Res; 1995 Jun; 76(6):1071-8. PubMed ID: 7758161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular recovery using calcium protease inhibition after median nerve repair in primates.
    Badalamente MA; Hurst LC; Stracher A
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5983-7. PubMed ID: 2548194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilizing neuromuscular contacts reduces motoneuron death caused by paralysis of muscles in neonatal rats.
    Harding DI; Greensmith L; Vrbová G
    Neuroscience; 1999; 93(3):1141-6. PubMed ID: 10473278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.
    Kobayashi Y; Yamamoto K; Saido T; Kawasaki H; Oppenheim JJ; Matsushima K
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5548-52. PubMed ID: 2115174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple calcium-activated neutral proteinases (CANP) in mouse retinal ganglion cell neurons: specificities for endogenous neuronal substrates and comparison to purified brain CANP.
    Nixon RA; Quackenbush R; Vitto A
    J Neurosci; 1986 May; 6(5):1252-63. PubMed ID: 3012011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-activated neutral protease (CANP), a putative processing enzyme of the neuropeptide, kyotorphin, in the brain.
    Yoshihara Y; Ueda H; Imajoh S; Takagi H; Satoh M
    Biochem Biophys Res Commun; 1988 Sep; 155(2):546-53. PubMed ID: 2844173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of calcium-activated neutral protease (CANP) in the peripheral nerve.
    Kamakura K; Ishiura S; Fujita T; Nonaka I; Sugita H
    Muscle Nerve; 1985 Jun; 8(5):380-2. PubMed ID: 16758583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and inhibition of calcium-activated neutral protease (CANP) in primate skeletal muscle and peripheral nerve.
    Badalamente MA; Hurst LC; Stracher A
    Exp Neurol; 1987 Nov; 98(2):357-69. PubMed ID: 2822459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reorganization of synaptic inputs to developing skeletal muscle fibres.
    Vrbová G; Lowrie MB; Evers J
    Ciba Found Symp; 1988; 138():131-51. PubMed ID: 3197514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of the epidermal growth factor receptor by endogenous calcium-activated neutral protease from rat liver.
    Gates RE; King LE
    Biochem Biophys Res Commun; 1983 May; 113(1):255-61. PubMed ID: 6305351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors reduce the loss of nerve terminals induced by activity and calcium in developing rat soleus muscles in vitro.
    O'Brien RA; Ostberg AJ; Vrbova G
    Neuroscience; 1984 Jun; 12(2):637-46. PubMed ID: 6379504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Ca2+-activated neutral protease in the peripheral nerve and its effects on neurofilament degeneration.
    Kamakura K; Ishiura S; Sugita H; Toyokura Y
    J Neurochem; 1983 Apr; 40(4):908-13. PubMed ID: 6300327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction by intracellular calcium chelation of acetylcholine secretion without occluding the effects of adenosine at frog motor nerve endings.
    Hunt JM; Redman RS; Silinsky EM
    Br J Pharmacol; 1994 Mar; 111(3):753-8. PubMed ID: 8019754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings.
    Silinsky EM
    Anesthesiology; 2013 Aug; 119(2):326-34. PubMed ID: 23535502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of the small (30K) subunit of calcium-activated neutral protease (CANP).
    Suzuki K; Emori Y; Ohno S; Imahori S; Kawasaki H; Miyake S
    Biomed Biochim Acta; 1986; 45(11-12):1487-91. PubMed ID: 3034236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function.
    Suzuki K; Imajoh S; Emori Y; Kawasaki H; Minami Y; Ohno S
    FEBS Lett; 1987 Aug; 220(2):271-7. PubMed ID: 3038617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of short-term forms of synaptic plasticity].
    Zefirov AL; Mukhamed'iarov MA
    Ross Fiziol Zh Im I M Sechenova; 2004 Aug; 90(8):1041-59. PubMed ID: 15552370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.